Compare XPL & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XPL | PETS |
|---|---|---|
| Founded | 1984 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Retail-Drug Stores and Proprietary Stores |
| Sector | Basic Materials | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.6M | 63.7M |
| IPO Year | N/A | N/A |
| Metric | XPL | PETS |
|---|---|---|
| Price | $0.74 | $3.41 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 2 | 1 |
| Target Price | $1.20 | ★ $3.20 |
| AVG Volume (30 Days) | 228.6K | ★ 954.8K |
| Earning Date | 10-31-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $198,265,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.54 | $1.57 |
| 52 Week High | $0.90 | $5.58 |
| Indicator | XPL | PETS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 58.33 |
| Support Level | N/A | $3.23 |
| Resistance Level | N/A | $3.52 |
| Average True Range (ATR) | 0.00 | 0.16 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 46.34 |
Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.